Jian Yan

Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Southern Medical University

Affiliated withThe Third Affiliated Hospital of Southern Medical University

Research Area

Biography

Jian Yan has not added Biography.
If you are Jian Yan and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2026

Other Publications

Article	Year
Prevalence and clinical relevance of T-helper cells, Th17 and Th1, in hepatitis B virus-related hepatocellular carcinoma. PloS one\| PubMed ID: 24867183	2014
Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis. Asian Pacific journal of cancer prevention : APJCP\| PubMed ID: 25684532	2015
Comparison of Various Strategies for the Prognosis and Outcomes of Ischaemic Dilated Cardiomyopathy in Smokers: Complete Revascularisation and Smoking Cessation Produces a Superior Outcome. Heart, lung & circulation\| PubMed ID: 27743853	2017
HIF-2α and Oct4 have synergistic effects on survival and myocardial repair of very small embryonic-like mesenchymal stem cells in infarcted hearts. Cell death & disease\| PubMed ID: 28079892	2017
RASSF6 downregulation promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal cancer. Oncotarget\| PubMed ID: 28903410	2017
Expression of miRNA-146b-5p in patients with thyroid cancer in combination with Hashimoto's disease and its clinical significance. Oncology letters\| PubMed ID: 31186695	2019
Hepatic artery intervention combined with immune-targeted therapy is superior to sequential therapy in BCLC-C hepatocellular carcinoma. Journal of cancer research and clinical oncology\| PubMed ID: 36454282	2023
Efficacy and safety of different PD-1 inhibitors in combination with lenvatinib in the treatment of unresectable primary liver cancer: a multicentre retrospective study. Discover oncology\| PubMed ID: 37336826	2023
Targeting PDGF-CC as a promising therapeutic strategy to inhibit cholangiocarcinoma progression. Journal of translational medicine\| PubMed ID: 39543636	2024
Efficacy and conversion outcome of chemotherapy combined with PD-1 inhibitor for patients with unresectable or recurrent gallbladder carcinoma: a real-world exploratory study. World journal of surgical oncology\| PubMed ID: 40022061	2025
Meta-analysis of risk factors for recurrent gestational diabetes mellitus. BMC pregnancy and childbirth\| PubMed ID: 40057727	2025
Expression and clinical significance of the imprinted gene PHLDA2 in colorectal cancer. Cancer genetics\| PubMed ID: 41183464	2025
Prognostic prediction and immune microenvironment analysis in colorectal cancer using exosome-related lncRNA signatures. Discover oncology\| PubMed ID: 41806199	2026
Cancer-associated fibroblast-derived stanniocalcin 1 promotes cholangiocarcinoma progression and lymph node metastasis. Fundamental research\| PubMed ID: 41971827	2026